MERXIN

Live / Registered — Registered — international registration renewed (as of 17 Jul 2025)

What this means for you

Registered since 23 Apr 2019. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79229680
Registration number
5730393
Mark type
Stylized text
Filed
18 Jan 2018
Published for opposition
05 Feb 2019
Registered
23 Apr 2019
Attorney of record
Geza C Ziegler Jr

Goods and services

  • Class 005 — Pharmaceuticals: [ Pharmaceuticals for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders adapted for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical compositions for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders adapted for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical preparations for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical preparations for inhalers, namely, medical pharmaceutical compositions for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders structured for delivery into the body by nebulizer, aerosol, or dry powder, via the lungs or via the nasal passageway; Dietary supplements; Pharmaceutical products for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders ]
  • Class 009 — Scientific and electric apparatus: [ Vials for scientific purposes being laboratory equipment; Vials for laboratory use; Glass tubes for scientific purposes being laboratory equipment ] * Laboratory equipment for scientific purposes, namely, vials *
  • Class 010 — Medical apparatus: * medical inhalers that are sold empty and in bulk via business-to-business transactions through business-to-business channels of trade * [ [ Surgical, medical, dental and veterinary apparatus and instruments, namely, injection devices for administering drugs sold empty; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Medical syringes sold empty for administering pharmaceuticals; Medical apparatus for introducing pharmaceutical preparations into the human body; Inhalers for medical use; ] Medical inhalers * Sold Empty * [ ; Respiratory monitors for medical use; Apparatus for measuring lung function; Spirometers for examining the function of the lungs; Spirometers; Spirometer mouth pieces and tubing; breath gas analyzers for medical diagnostics; Replacement cartridges for medical inhalers sold empty; Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of asthma and respiratory diseases ] ]
  • Class 042 — Scientific and technological services: * design and development of medical inhalers sold empty and in bulk to third-party drug manufacturers and not for sale directly to end users * [ Scientific and technological services, namely, research and design in the field of drug delivery via the lungs or via the nasal passageway; Scientific and technological design of new products for others; Advisory services relating to [ design engineering ] * design of new products for others * ; Advisory services relating to [ product testing ] * testing of new products for others * ; Product design and development in the field of drug delivery via the lungs or via the nasal passageway; New product design services, namely, analysis and evaluation of product design; [ engineering design and consultancy ] * new product design and consultancy services * ; Professional consultancy relating to medical technology; [ engineering project management services, not for business purposes; Engineering research ] * project management services in the field of medical and pharmaceutical engineering, not for business purposes; Scientific research in the field of medical and pharmaceutical engineering * ; Pharmaceutical research and development services; research and development for the pharmaceutical industry; Research relating to medicines ]
  • Class 044 — Medical, beauty and agricultural services: [ Pharmaceutical compounding services; Pharmaceutical compounding consultation services; Pharmaceutical compounding advisory services; Medical services; Veterinary services; Hygienic and beauty care for animals; Hygienic and beauty care for humans ]

Owner

Prosecution history

  • 17 Jul 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
  • 17 Jul 2025 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
  • 15 Jul 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 22 Apr 2025 — TEAS SECTION 71 & 15 RECEIVED
  • 17 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 17 Apr 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
  • 17 Apr 2025 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
  • 17 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 17 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 16 Jun 2024 — NEW REPRESENTATIVE AT IB RECEIVED
  • 02 May 2024 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
  • 23 Apr 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
  • 23 Apr 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
  • 24 Aug 2023 — NOTICE OF PARTIAL CANCELLATION SEC. 7 SURRENDER EMAILED
  • 23 Aug 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL

View this trademark record on Marksy